ArticleScience translational medicine2022

Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.

Thomas S Uldrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.